306 related articles for article (PubMed ID: 11806989)
1. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
Myers LA; Patel DD; Puck JM; Buckley RH
Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
[TBL] [Abstract][Full Text] [Related]
2. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
[TBL] [Abstract][Full Text] [Related]
3. Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S; Sullivan KE; Small TN; Burroughs L; Skoda-Smith S; Haight AE; Grizzle A; Pulsipher MA; Chan KW; Fuleihan RL; Haddad E; Loechelt B; Aquino VM; Gillio A; Davis J; Knutsen A; Smith AR; Moore TB; Schroeder ML; Goldman FD; Connelly JA; Porteus MH; Xiang Q; Shearer WT; Fleisher TA; Kohn DB; Puck JM; Notarangelo LD; Cowan MJ; O'Reilly RJ
N Engl J Med; 2014 Jul; 371(5):434-46. PubMed ID: 25075835
[TBL] [Abstract][Full Text] [Related]
4. T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.
Sarzotti M; Patel DD; Li X; Ozaki DA; Cao S; Langdon S; Parrott RE; Coyne K; Buckley RH
J Immunol; 2003 Mar; 170(5):2711-8. PubMed ID: 12594301
[TBL] [Abstract][Full Text] [Related]
5. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.
Buckley RH
Immunol Res; 2011 Apr; 49(1-3):25-43. PubMed ID: 21116871
[TBL] [Abstract][Full Text] [Related]
7. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
[TBL] [Abstract][Full Text] [Related]
9. Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).
McWilliams LM; Dell Railey M; Buckley RH
J Allergy Clin Immunol Pract; 2015; 3(4):585-91. PubMed ID: 25824440
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and HSCT Outcome for SCID in Turkey.
Ikinciogullari A; Cagdas D; Dogu F; Tugrul T; Karasu G; Haskologlu S; Aksoylar S; Uygun V; Kupesiz A; Yildiran A; Gursel O; Ates C; Elhan A; Kansoy S; Yesilipek A; Tezcan I;
J Clin Immunol; 2019 Apr; 39(3):316-323. PubMed ID: 30924026
[TBL] [Abstract][Full Text] [Related]
11. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
12. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
[TBL] [Abstract][Full Text] [Related]
13. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
[TBL] [Abstract][Full Text] [Related]
14. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.
Borghans JA; Bredius RG; Hazenberg MD; Roelofs H; Jol-van der Zijde EC; Heidt J; Otto SA; Kuijpers TW; Fibbe WE; Vossen JM; Miedema F; van Tol MJ
Blood; 2006 Jul; 108(2):763-9. PubMed ID: 16822903
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output.
Pirovano S; Notarangelo LD; Malacarne F; Mazzolari E; Porta F; Lanfranchi A; Giliani S; Zucca S; Pecorelli S; Albertini A; Ugazio AG; Imberti L
Haematologica; 2004 Apr; 89(4):450-61. PubMed ID: 15075079
[TBL] [Abstract][Full Text] [Related]
16. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
[TBL] [Abstract][Full Text] [Related]
17. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
Kwan A; Church JA; Cowan MJ; Agarwal R; Kapoor N; Kohn DB; Lewis DB; McGhee SA; Moore TB; Stiehm ER; Porteus M; Aznar CP; Currier R; Lorey F; Puck JM
J Allergy Clin Immunol; 2013 Jul; 132(1):140-50. PubMed ID: 23810098
[TBL] [Abstract][Full Text] [Related]
18. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
[TBL] [Abstract][Full Text] [Related]
19. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.
Blazar BR; Taylor PA; McElmurry R; Tian L; Panoskaltsis-Mortari A; Lam S; Lees C; Waldschmidt T; Vallera DA
Blood; 1998 Nov; 92(10):3949-59. PubMed ID: 9808589
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
